# Inadvertent Salbutamol Overdose Presenting as Acute Toxicity

**Authors:** Shaikh Mohammed Aslam, Aadithya Shyllesh H, Vaibhav Siddarth TS, Mohammed Suhail K, Ashwin Kulkarni

PMC · DOI: 10.7759/cureus.95282 · Cureus · 2025-10-24

## TL;DR

A young woman with asthma experienced seizures and unconsciousness after overdosing on salbutamol, leading to cardiac and metabolic complications.

## Contribution

This case highlights the acute toxicity risks of salbutamol overdose and emphasizes the importance of proper medication use.

## Key findings

- Overdose led to seizures, unconsciousness, and cardiac arrhythmias.
- Metabolic issues like hyperglycemia, lactic acidosis, and hypokalemia were observed.
- Conservative ICU management and medication optimization led to recovery.

## Abstract

Salbutamol is a short-acting beta-2 agonist available in inhalational and oral formulations for the treatment of asthma and chronic obstructive pulmonary disease due to its ability to rapidly relieve bronchospasm. However, because of its quick onset of action, it is recommended only as rescue therapy in mild cases with minimal symptoms and without nocturnal awakenings. Owing to its efficacy, salbutamol carries a potential risk of misuse or overuse among asthmatic patients. We report the case of a young woman with a long-standing history of asthma who presented with seizures followed by loss of consciousness after consuming multiple salbutamol tablets in succession. Neuroimaging (MRI brain) and electroencephalogram findings were normal. Further evaluation revealed cardiac arrhythmias, metabolic dysfunction characterized by hyperglycemia and lactic acidosis, and hypokalemia. She was managed conservatively in the ICU. After stabilization, her asthma medications were optimized, and she was discharged with education on the appropriate use of salbutamol to prevent recurrence of toxicity.

## Linked entities

- **Chemicals:** salbutamol (PubChem CID 2083)
- **Diseases:** asthma (MONDO:0004979), chronic obstructive pulmonary disease (MONDO:0005002)

## Full-text entities

- **Diseases:** hypokalemia (MESH:D007008), bronchospasm (MESH:D001986), chronic obstructive pulmonary disease (MESH:D029424), asthmatic (MESH:D013224), asthma (MESH:D001249), seizures (MESH:D012640), metabolic dysfunction (MESH:D008659), loss of consciousness (MESH:D014474), hyperglycemia (MESH:D006943), lactic acidosis (MESH:D000140), cardiac arrhythmias (MESH:D001145), Toxicity (MESH:D064420)
- **Chemicals:** beta-2 agonist (-), Salbutamol (MESH:D000420)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640462/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12640462/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640462/full.md

---
Source: https://tomesphere.com/paper/PMC12640462